来曲唑用于多囊卵巢综合征患者促排卵的临床疗效及安全性评价OA北大核心CSCDCSTPCD
Clincial effect and safety of letrozole for promoting ovulation in the patients with polycystic ovarian syndrome
目的 评价不同剂量来曲唑用于多囊卵巢综合征患者促排卵的临床疗效和安全性. 方法 将88例拟进行促排卵治疗的多囊卵巢综合征患者随机分为对照组42例和试验组46例. 2组患者均于月经来潮第3天起开始服药,对照组予以口服来曲唑2.5 mg? d-1 ,连续5 d;试验组予以口服来曲唑5 mg? d-1 ,连续5 d. 月经周期第10天,开始进行阴道超声检查,并监测卵泡发育情况,比较2组患者的排卵率和周期妊娠率以及不良反应发生率. 结果 对照组有33例排…查看全部>>
Objective To evaluate the promoting ovulation effects of different dosage of letrozole in the treatment of patients with polycystic ovarian syndrome ( POS) .Methods Eighty -eight patients with POS were randomly divided into control group ( n=42 ) and treatment group (n=46).Patients in two groups began to take drug in the third day of menstruation.Patients in the control group were treated with letrozole 2.5 mg? d-1 for 5 days.Patients in the treatment group …查看全部>>
韦娟冰
福建医科大学 附属第一医院 妇产科,福州350005
医药卫生
多囊卵巢综合征来曲唑不同剂量促排卵治疗
polycystic ovarian syndromeletrozoledifferent dosagepromoting ovulation
《中国临床药理学杂志》 2015 (19)
1928-1930,3
福建省卫生厅青年基金资助项目(0013023)
评论